Ambassador Peter F. Secchia Lecture
Tue, October 10, 2023 6:30 AM - Tue, October 10, 2023 8:00 AM at MSU College of Human Medicine Secchia Center, 15 Michigan Street NE, Grand Rapids
Please join us.
You are invited to breakfast on October 10 for an engaging Alzheimer’s disease presentation at the inaugural Ambassador Peter F. Secchia Lecture. Hosted by Michigan State University College of Human Medicine, this lecture series celebrates Ambassador Secchia's spirit of collaboration and innovation. For our first lecture, the college warmly welcomes Jeffrey L. Dage, PhD, senior research professor of neurology at Indiana University School of Medicine. Please RSVP by October 3.
Tuesday, October 10
7:30 a.m. — 9:00 a.m.
- Location: MSU College of Human Medicine Secchia Center
15 Michigan Street NE, Grand Rapids. - Complimentary breakfast will be served.
- Questions? Contact Melissa Kacos at kacosmel@msu.edu.
Blood-Based Tests to Aid in an Alzheimer’s Disease Diagnosis – Clinical Practice and Research Uses
Recent scientific breakthroughs have led to the development of new blood tests that can help aid in the diagnosis of Alzheimer’s disease. Dr. Dage will provide an overview of some of these tests and explain what they measure and how they work. Finally, examples of potential uses in clinical practice and Alzheimer’s disease research will be shared.
About the Speaker
Jeffrey L. Dage, PhD, is a senior research professor of neurology and primary member of the Stark Neurosciences Research Institute at Indiana University School of Medicine. He holds a secondary appointment in the Department of Medical and Molecular Genetics. He has more than 20 years of experience in drug discovery and early clinical development holding roles as an individual contributor, scientific group leader and management.
Dr. Dage has continually been on the forefront of identification, development, and application of novel technologies that answer disease relevant biological questions encountered in the course of drug discovery and clinical development. Most recently, he led the discovery and development of phosphorylated tau as a novel blood biomarker for Alzheimer’s disease clinical trials.
About the Series
The Ambassador Peter F. Secchia Lecture Series encourages collaboration among biomedical researchers, faculty, students, and entrepreneurs within the medical industry. Made possible by philanthropic support from the Secchia family, the series was established in 2023 by the Michigan State University College of Human Medicine to support the value of free enterprise as it pertains to medical research. It features biomedical researchers, medical industry entrepreneurs and business executives, and other experts from the health care community.
RSVP for October 10 Ambassador Peter F. Secchia Lecture Series